Investment Bank for the Healthcare Sector

With insights and relationships throughout the healthcare ecosystem, our team excels at securing ideal partners to create value for our clients.

Connect with us

70

healthcare transactions in 2022

>30%

of M&A healthcare transactions were cross-border in 2022

Providing Quality Outcomes for Healthcare Clients

Healthcare is one of the most dynamic and complex areas in the global economy. Healthcare leaders who want to capitalize on rapid changes in science, regulation, technology and therapeutics benefit from the expertise of investment banking advisors with relevant experience and a keen focus on their unique goals. Our passion for healthcare and our focus on creating shareholder value for our clients has made us one of the fastest growing investment banking advisors for healthcare sector.

Sector Focus

Provider Services

Home Healthcare
Physician Services
Outpatient Services
Pharmacy Services

Pharmaceutical & Lab Services

Contract Research Organizations
Analytical Lab Services
Clinical Lab Services
Contract Manufacturing
Medical Communications

Process Outsourcing

Hospital Outsourcing
Revenue Cycle Management
Employer Health Services
Healthcare IT

Medical Devices & Outsourcing

Devices & Equipment
Products & Supplies
Medical Components
Contract Design / Manufacturing

Life Sciences

Diagnostic Instruments
Research Equipment
Lab Supplies
Consumables & Kits

Managed Care

Health Plans
Third-Party Administration
Benefits Management
Payor Outsourced Services

Perspectives & Publications

Scrip | What Does 2023 Hold for Biopharma?

Originally posted by Scrip on January 9, 2023. Tony Crisman, Managing Director in Lincoln’s Healthcare Group, shares his predictions for biopharma mergers and acquisitions (M&A) trends in 2023. View the… Read More

What’s Old is New Again: Value-Based Care Delivery in the Home

In 1930, physicians visiting patients in their residences represented 40 percent of all encounters. 20 years later this figure had fallen dramatically to just one visit in 10. By the… Read More

In Vivo Pharma Intelligence | The Growth Path for Drug Discovery Partners

Originally published by In Vivo Pharma Intelligence on November 15, 2022 James West, Director in Lincoln’s Healthcare Group, explains the key trends and mergers and acquisitions (M&A) dynamics in the… Read More

Lincoln’s Latest

In Q3 2020, Lincoln International introduced Lincoln’s Latest video series. Experts from across industries, services and geographies, share perspectives on current trends, recent observations and future outlooks through this video… Read More

Lincoln’s expertise in healthcare services and with private companies, combined with their process execution capabilities, proved to be invaluable. At all times the Lincoln team acted as a trusted advisor and truly understood the needs of an owner-entrepreneur."
Avo Minasyan
Co-Founder and CEO, TNH
Healthcare

American & European Healthcare Group Heads

Meet our Senior Team with Healthcare Expertise